BioAge Labs, Inc.

BIOA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$20-$22-$13-$21
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$3$3$3$3
Change in WC$1-$2-$8$14
Other Non-Cash$0$0$0-$0
Operating Cash Flow-$16-$20-$17-$5
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$13-$24-$78$0
Inv. Sales/Matur.$26$9$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$13-$16-$78-$0
Financing Activities
Debt Repay.-$2-$2-$2-$2
Stock Issued$0$0$0$28
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$0-$1
Financing Cash Flow-$2-$2-$2$25
Forex Effect-$0-$0-$0$0
Net Chg. in Cash-$5-$37-$97$20
Supplemental Information
Beg. Cash$220$257$354$334
End Cash$216$220$257$354
Free Cash Flow-$16-$20-$18-$5
BioAge Labs, Inc. (BIOA) Financial Statements & Key Stats | AlphaPilot